Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Genitourinary Cancer|November 12, 2025
Trends in Treatment Patterns and Outcomes Among Patients Diagnosed With Nonmuscle-Invasive Bladder Cancer in the United StatesBernard Bright Davies-Teye, Dominique Seo, Abree Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
Reduced risk of dementia with recombinant zoster vaccine in US adults age 65 or olderSusan Dos Reis, Phuong Tran, Kareshma Mohanty, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2022
The economic burden of Parkinson disease among Medicare beneficiariesHusam Albarmawi, Shujia Zhou, Lisa M Shulman, et al.
Neurology|May 28, 2021
Health Care Resource Utilization Associated With Parkinson Disease Among Medicare BeneficiariesAakash Bipin Gandhi, Eberechukwu Onukwugha, Husam Albarmawi, et al.
The Gerontologist|April 22, 2026
Medication Refill Patterns and Mortality in U.S. Adults Aged 85+: A Retrospective Medicare Cohort StudyNadim Ojaimi, Brock A Beamer, Raymond H Kheirbek, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2024
Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemiaTsung-Ying Lee, Abree Johnson, Catherine E Cooke, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 7, 2020
Practice patterns of board-certified sleep medicine providers: a national analysis among older adult Medicare beneficiariesEmerson M Wickwire, Jennifer S Albrecht, Jennifer J Dorsch, et al.
The American Journal of Managed Care|June 26, 2018
Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013Bruce C Stuart, Sarah E Tom, Michelle Choi, et al.
Seminars in Arthritis and Rheumatism|July 24, 2024
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 yearsChengchen Zhang, Alejandro Amill-Rosario, Abree Johnson, et al.
Pageof 3